The 19th Annual Meeting of the Pan American Society for Pigment Cell Research Conference
泛美色素细胞研究学会第十九届年会
基本信息
- 批准号:8986392
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmericanAreaArgentinaAsiansBiogenesisBiologyBrazilCaliforniaCanadaCellsCellular biologyChileClinicalCollaborationsCutaneousDevelopmentDisciplineDiseaseDoctor of MedicineEtiologyEuropeEuropeanEventFacultyGenomicsGoalsHair follicle structureHealthIndividualInstitutesInternationalInterventionJapanese PopulationKnowledgeLeadMalignant - descriptorMedicalMedical centerMelaninsMentorshipMexicoNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNatureNerve DegenerationNeurodegenerative DisordersNon-MalignantOrangesOrganellesOrphanParkinson DiseaseParkinsonian DisordersPigmentsPreventionProcessPublic HealthResearchResearch PersonnelRoleScientistSocietiesStem cellsUnderrepresented MinorityUnited StatesUnited States National Institutes of HealthUniversitiesVitiligoWomanWorkcareerdemographicsdesignexperienceforginginterestmeetingsmelanocytemelanomamembermultidisciplinaryneglectnovelprogramspublic health relevancestem cell biologysymposium
项目摘要
DESCRIPTION (provided by applicant): The Pan-American Society for Pigment Cell Research (PASPCR) is preparing to hold the 19th Annual PASPCR Conference in Orange, California on September 27-30, 2015, spearheaded by founding PASPCR member, Dr. Frank L. Meyskens, Jr., M.D. The University of California, Irvine will be the applicant organization. The conference will be held directly across the street from UCI Medical Center at the DoubleTree Hotel (and conference rooms), which has extensive experience sponsoring medical, scientific, and other UC Irvine Health events. The 2015 PASPCR Conference theme, "The Melanocyte and Its Multiple Niches: New Biology in Health and Disease" will summarize recent advances in pigment cell biology and focus on the role of melanocyte stem cells in both malignant and non-malignant disorders. A unique feature of the meeting is the focused symposium on "inner melanin (and its formation and degradation)" in health and disease, which will focus on neurodegenerative processes such as Alzheimer's and Parkinson's disease. The broad-ranging theme of the symposium reflects the multidisciplinary, collaborative nature of UC Irvine, which has investigators that focus on both pigment cell biology and neurodegenerative disease processes. The scientific organizing committee has identified several basic scientists and clinical experts from across the United States and Europe to participate in the conference as invited speakers. These individuals have been asked to provide a brief historic perspective on their chosen topic, present the latest findings from their research, and highlight current challenges and opportunities in and across diverse fields related to their work. The ultimate goal of this symposium is to stimulate interdisciplinary discussions between clinicians, basic researchers, neuroscientists, and pigment cell researchers which will eventually lead to new collaborations. Although members of PASPCR participate in other traditional discipline-oriented conferences, this forum is unique in that it brings together investigators from different disciplines, with a diversity of interests, in an intimate setting in order to spawn new scientific
interactions and collaborations. The overall objective of PASPCR 2015 is to increase our knowledge of the normal and abnormal biology of the melanocyte, especially as related to stem cells and the neglected area of melanin's potential involvement in neurodegenerative diseases. The specific aims of the 2015 annual PASPCR are: (1) To highlight recent advances in organelle biogenesis, genomics and stem cell biology as they relate to melanocyte development and melanocyte transformation. (2) To bring together basic scientists, clinical scientists, neuroscientists, and melanocyte biologists in order to forge new scientific collaborations that wil lead to advances in the treatment of orphan pigmentary disorders and neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. (3) To provide mentorship to young investigators who are developing careers in the fields of neurodegeneration and melanocyte biology, with a specific focus on women and underrepresented minorities.
描述(由申请人提供):泛美色素细胞研究学会(PASPCR)正准备于2015年9月27日至30日在加州的橙子举行第19届PASPCR年会,由PASPCR创始成员Frank L.小梅斯肯斯,M.D.加州尔湾大学将是申请组织。会议将直接在DoubleTree酒店(和会议室)的UCI医疗中心对面举行,该酒店拥有赞助医疗,科学和其他UC Irvine Health活动的丰富经验。2015年PASPCR会议的主题是“黑素细胞及其多个利基:健康和疾病的新生物学”,将总结色素细胞生物学的最新进展,并重点关注黑素细胞干细胞在恶性和非恶性疾病中的作用。会议的一个独特之处是重点讨论健康和疾病中的“内部黑色素(及其形成和降解)”,重点讨论阿尔茨海默病和帕金森病等神经退行性过程。研讨会的广泛主题反映了UC Irvine的多学科协作性质,该研究人员专注于色素细胞生物学和神经退行性疾病过程。科学组委会已经确定了来自美国和欧洲的几位基础科学家和临床专家作为特邀演讲人参加会议。这些人被要求就他们所选择的主题提供一个简短的历史观点,介绍他们的研究的最新发现,并强调当前的挑战和机遇,并在与他们的工作相关的各个领域。本次研讨会的最终目标是激发临床医生,基础研究人员,神经科学家和色素细胞研究人员之间的跨学科讨论,最终将导致新的合作。虽然PASPCR的成员参加其他传统的学科导向的会议,这个论坛是独一无二的,因为它汇集了来自不同学科的研究人员,在一个亲密的环境,以产生新的科学
互动和协作。PASPCR 2015的总体目标是增加我们对黑素细胞的正常和异常生物学的了解,特别是与干细胞和被忽视的黑素参与神经退行性疾病的潜在领域有关的知识。2015年度PASPCR的具体目标是:(1)突出细胞器生物发生,基因组学和干细胞生物学的最新进展,因为它们与黑素细胞发育和黑素细胞转化有关。(2)汇集基础科学家,临床科学家,神经科学家和黑素细胞生物学家,以建立新的科学合作,从而促进孤儿色素性疾病和神经退行性疾病的治疗,包括阿尔茨海默病和帕金森病。(3)为正在神经变性和黑素细胞生物学领域发展事业的年轻研究人员提供指导,特别关注妇女和代表性不足的少数民族。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANK L. MEYSKENS其他文献
FRANK L. MEYSKENS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANK L. MEYSKENS', 18)}}的其他基金
7th International Conference on Clinical Cancer Prevention 2012 with Consensus Co
2012 年第七届临床癌症预防国际会议与共识公司
- 批准号:
8400378 - 财政年份:2013
- 资助金额:
$ 2.5万 - 项目类别:
University of California, Irvine Cancer Center Support Grant
加州大学欧文分校癌症中心支持补助金
- 批准号:
7929965 - 财政年份:2009
- 资助金额:
$ 2.5万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 2.5万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别: